Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07215221 · ClinicalTrials.gov registry record · NA

Implementation of TBI-RECOVER in Substance Use Treatment

A NA study, sponsored by Ohio State University.

Recruiting
Registry status
NA
Development phase
900
Enrollment target

NCT07215221 is a NA study that is actively recruiting participants, run by Ohio State University. The registered enrollment target is 900 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07215221, a NA study, is actively recruiting participants, sponsored by Ohio State University.

RECRUITING
Registry status
NA
Development phase
900 participants
Enrollment target

Study Summary

The goal of this hybrid type 2 pilot trial is to understand the implementation and effectiveness of the TBI-RECOVER intervention model (e.g., brain injury screening, cognitive and behavioral challenges screening, and neurocognitive accommodations) on patient retention in outpatient substance use disorder treatment. We will evaluate whether an implementation strategy bundle (e.g., training/education, champions, audit \& feedback, facilitation) improves provider use and sustainability of the TBI-RECOVER intervention, and also whether the TBI-RECOVER intervention improves patient symptoms and treatment retention.

Interventions

  • BEHAVIORAL Control
  • BEHAVIORAL TBI-RECOVER

Trial Details

FieldValue
Enrollment Target 900 participants
Start Date 2026-04-28
Est. Completion 2030-03-30
Phase NA

Sponsor

Ohio State University

552 total trials

What the Registry Record Tells You About NCT07215221

The ClinicalTrials.gov registry entry for NCT07215221 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 900 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.

NCT07215221 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07215221 about?

NCT07215221 is a clinical study titled "Implementation of TBI-RECOVER in Substance Use Treatment". The goal of this hybrid type 2 pilot trial is to understand the implementation and effectiveness of the TBI-RECOVER intervention model (e.g., brain injury screening, cognitive and behavioral challenges screening, and neurocognitive accommodations) on patient retention in outpatient substance use dis...

What is the current status of trial NCT07215221?

This trial is currently recruiting. It is a NA study. The enrollment target is 900 participants. The study started on 2026-04-28. Estimated completion is 2030-03-30.

What interventions are being tested in trial NCT07215221?

The interventions under investigation include: Control (BEHAVIORAL), TBI-RECOVER (BEHAVIORAL).

Who is sponsoring clinical trial NCT07215221?

This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.